Improvement of peripheral microcirculation using vasodilator treatment in patients with shock

Phase 1

• Conditions: Circulatory shock; Therapeutic area: Body processes [G] - Circulatory and Respiratory Physiological Phenomena [G09]

• Registration Number: EUCTR2013-002189-38-NL
• Lead Sponsor: Erasmus Medical Center

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2015-04-15
• Last Update Posted: 23 October 2017

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

All consecutive adult patients admitted to the intensive care for circulatory shock resuscitation in whom abnormal peripheral perfusion is still present despite normalization of global hemodynamic parameters are eligible for this study.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 140
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 140

Exclusion Criteria

Liver failure, severe coagulation disorder, and any neurological insult that could lead to increased intracranial pressure (stroke, subarachnoid haemorrhage, brain trauma injury).

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified